Skip to Content

Jennifer K. Burzawa, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
Regional Care Center Katy
19770 Kingsland Blvd, Ste. 200
Unit Number: 2052
Houston, TX 77094
Phone: 713-563-9600
Fax: 281-646-4320

Education & Training

Degree-Granting Education

2000 University of Miami, Coral Gables, FL, BS, Medicine

Postgraduate Training

2008-2012 Clinical Fellowship, Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
2006 Fellowship, Felix Rutledge Fellowship - Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
2004-2008 Clinical Residency, Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX

Board Certifications

11/2013 American Board of Obstetrics and Gynecology


Institutional Committee Activities

Member, Fellowship admissions Subcommittee, 2010-2011
Member, Fellowship Didactic Curriculum Subcommittee, 2010
Member, Fellowship Planning Committee, 2009-2010

Honors and Awards

2010 2010 Oncology Trainee Travel Award, American Society of Cancer Oncologists
2009 Population/Patient-Oriented Research - 2nd place, The University of Texas MD Anderson Cancer Center
1998-2004 Honors Program in Medicine, University of Miami
1997 Student Science Training Program, University of Florida

Selected Publications

Peer-Reviewed Original Research Articles

1. Daniels MS, Burzawa JK, Brandt AC, Schmeler KM, Lu KH. A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges. Fam Cancer 10(2):193-7, 6/2011. PMCID: PMC4286250.
2. Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KH. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol 204(4):355.e1-7, 4/2011. e-Pub 2/16/2011. PMCID: PMC4286377.
3. Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, Yzquierdo R, Lynch P, Peterson SK, Lu K. Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. J Oncol Pract 7(1):43-7, 1/2011. PMCID: PMC3014510.
4. Nick AM, Schmeler KM, Frumovitz MM, Soliman PT, Spannuth WA, Burzawa JK, Coleman RL, Wei C, dos Reis R, Ramirez PT. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol 116(4):956-61, 10/2010. PMID: 20859161.
5. Li Z, Burzawa JK, Troung A, Feng S, Agoulnik IU, Tong X, Anderson ML, Kovanci E, Rajkovic A, Agoulnik AI. Relaxin signaling in uterine fibroids. Ann N Y Acad Sci 1160:374-8, 4/2009. PMCID: PMC2954601.
6. Latchaw G, Takacs P, Gaitan L, Geren S, Burzawa J. Risk factors associated with the rupture of tubal ectopic pregnancy. Gynecol Obstet Invest 60(3):177-80, 2005. e-Pub 9/2/2005. PMID: 16141721.
7. Kraus G, Geffin R, Spruill G, Young AK, Seivright R, Cardona D, Burzawa J, Hnatyszyn HJ. Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences. Proc Natl Acad Sci U S A 99(6):3406-11, 3/19/2002. PMCID: PMC122536.

Last updated: 8/11/2015